Codice QR

Shifting Paradigms in TNBC Treatment: Emerging Alternatives to Capecitabine in the Post-Neoadjuvant Setting

Background: Triple-negative breast cancer (TNBC) remains a clinically challenging subtype due to its aggressive nature and limited treatment options post-neoadjuvant failure. Historically, capecitabine has been the cornerstone of adjuvant therapy for TNBC patients not achieving a pathological comple...

Descrizione completa

Salvato in:
Autori principali: Halima Abahssain, Amine Souadka, Rania Alem, Matteo Santoni, Nicola Battelli, Eric Amela, Antoine Lemaire, Joseph Rodriguez, Hassan Errihani
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2024-06-01
Serie:Current Oncology
Soggetti:
triple-negative breast cancer
capecitabine
immunotherapy
PARP inhibitors
antibody–drug conjugates
neoadjuvant therapy
Accesso online:https://www.mdpi.com/1718-7729/31/7/278
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi